The global controlled release drug delivery market size is estimated to reach USD 69.8 billion by 2027 registering a CAGR of 7.8% during the forecast period, according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems, such as increased therapeutic efficacy, less side effects, and low treatment cost are the factors driving the market growth.
These
technologies offer various benefits over traditional delivery forms, such as
reduced dosage and dosage frequency, enhanced patient compliance, less
gastrointestinal side effects, uniform drug effect, improved drug efficacy and
safety, and reduced fluctuation of plasma drug levels.
Presence
of multiple in-vivo biological barriers that affects the absorption,
bioavailability, and stability of the drug has open wide horizon for the
controlled release drug delivery products. For instance, controlled release
drug delivery system has enabled delivery of even large and complex molecules
such as DNA/RNA, proteins and polypeptides. Additionally, the rising awareness
among healthcare professionals, regarding the advantage of controlled release
drug delivery systems over conventional systems is expected to drive the demand
for the market in long run.
Rapidly
increasing geriatric and pediatric population is one of the major factors
fueling the demand for controlled release drug delivery systems, due to high cases
prescription non-adherence in this age-group. Innovations in various drug
delivery systems has been providing geriatric and pediatric population with
easy solutions, which are further propelling the market. Controlled release of
drug delivery systems can be altered according to required dosage over a
specific period of time.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market
Controlled Release
Drug Delivery Market Report Highlights
- Based on
application, oral controlled release systems held the largest market share
in 2019 owing to increasing usage and ease of convenience offered for
administration of medication
- Targeted drug
delivery is poised to be the fastest growing technology segment during the
forecast period owing to various benefits of the technology, such as
increased safety and therapeutic efficacy
- Osmotic
delivery is projected to witness the fastest CAGR in the activation
modulation drug delivery systems during the forecast period, due to the
ability of this release mechanism to not be affected by various factors,
such as pH, food consumption, and gastrointestinal motility
- North America
held the largest market share in 2019 owing to the presence of developed
healthcare infrastructure facilities, increasing R&D activities and
existence of major market players
- Asia Pacific
is expected to post the highest CAGR during the forecast period owing to
rising investments by dominant players in the region along with
developments in the of pharmaceutical industry in emerging countries, such
as India and China
- Some of the
prominent companies operating in the controlled release drug delivery
market are Orbis Biosciences, Inc.; Merck and Co., Inc.; Alkermes
plc; Johnson and Johnson; Coating Place, Inc.; Corium International, Inc.;
Depomed, Inc.; Pfizer, Inc; Aradigm Corporation; and Capsugel
Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/controlled-release-drug-delivery-market/request/rs1
Controlled Release
Drug Delivery Market Segmentation
Grand View Research has
segmented the global controlled release drug delivery market on the basis of technology,
release mechanism, application, and region:
Controlled Release
Drug Delivery Technology Outlook (Revenue, USD Million, 2016 - 2027)
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others
Controlled Release
Drug Delivery Release Mechanism Outlook (Revenue, USD Million, 2016 - 2027)
- Polymer Based Systems
- Micro Reservoir Partition Controlled Drug
Delivery Systems
- Feedback Regulated Drug Delivery Systems
- Activation-modulated Drug Delivery Systems
- Osmotic Pressure Activated
- Hydrodynamic Pressure Activated
- Vapor Pressure Activated
- Mechanically Activated
- Magnetically Activated
- Chemically Activated
- pH Activated
- Hydrolysis Activated
- Enzyme Activated
Controlled Release
Drug Delivery Application Outlook (Revenue, USD Million, 2016 - 2027)
- Metered Dose Inhalers
- Injectable
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-drug Delivery Systems
- Drug Eluting Stents
Controlled Release
Drug Delivery Region Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Switzerland
- Netherland
- Sweden
- Spain
- Belgium
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Singapore
- Philippines
- Vietnam
- Indonesia
- Malaysia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Kuwait
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment